{"id":"W4205731320","doi":"10.1200/jco.2022.40.4_suppl.529","title":"Real-world cost-effectiveness of first-line gemcitabine + nab-paclitaxel versus FOLFIRINOX in patients with advanced pancreatic cancer: A population-based retrospective cohort study in Ontario, Canada.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ontario Institute for Cancer Research; Kingston Health Sciences Centre; Public Health Ontario; Sunnybrook Hospital; Canadian Centre for Applied Research in Cancer Control; Health Sciences Centre; Women's College Hospital; Cancer Care Ontario; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; University of Toronto","funders":"","keywords":"FOLFIRINOX; Medicine; Gemcitabine; Cost effectiveness; Propensity score matching; Cohort; Pancreatic cancer; Retrospective cohort study; Population; Randomized controlled trial; Oncology; Quality-adjusted life year; Internal medicine; Cancer; Irinotecan; Environmental health","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001162062,0.000487216,0.0007179172,0.000867759,0.001312628,0.0011149,0.001261265,0.0006526816,0.00183004],"category_scores_gemma":[0.003252386,0.0004895654,0.002193689,0.003067249,0.0006268448,0.0003690012,0.0006821189,0.0009200975,0.0001933523],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.04551898,"about_ca_system_score_gemma":0.03118283,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9735692,"about_ca_topic_score_gemma":0.9794779,"domain_scores_codex":[0.998832,0.0001482179,0.0001235733,0.0002163918,0.0003354049,0.0003442999],"domain_scores_gemma":[0.9969645,0.0002545612,0.001396539,0.0001453661,0.0006785708,0.0005604145],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0009716611,0.0001096077,0.992254,0.0001735385,0.0008931477,0.0001766224,0.0002754426,0.0006016826,0.0001484195,0.0001666156,0.00166523,0.002563886],"study_design_scores_gemma":[0.0003456287,0.0002372914,0.9943373,0.000125978,0.00072433,0.0001870567,0.0004649577,0.00171153,0.00006414476,0.00008864734,0.001679574,0.00003350069],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9869604,0.001414196,0.0001358012,0.0004197656,0.00001523795,0.0001640431,0.01000366,0.000008087399,0.0008786787],"genre_scores_gemma":[0.9945424,0.0005775447,0.0002611907,0.0001721081,0.00001220101,0.0000759869,0.003866046,0.000004328416,0.0004882419],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04551898,"threshold_uncertainty_score":0.3302649,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07156346936748291,"score_gpt":0.4373030759404299,"score_spread":0.365739606572947,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}